for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

シェンヂェン・サルブリス・ファーマスーティカルズ

002294.SZ

現在値

25.47CNY

変化

0.09(+0.35%)

出来高

4,617,602

本日のレンジ

24.93

 - 

25.59

52週レンジ

24.58

 - 

40.05

∙ 約20分前の相場を表示しています。

適時開示

Shenzhen Salubris Pharmaceuticals Raises Size For Share Buyback Scheme

Sept 6 (Reuters) - Shenzhen Salubris Pharmaceuticals Co Ltd <002294.SZ>::SAYS IT RAISES SIZE FOR SHARE BUYBACK SCHEME TO 200-400 MILLION YUAN ($30.99-61.98 million) FROM 100-200 MILLION YUAN.

Shenzhen Salubris Pharmaceuticals Plans Share Buyback Scheme

July 25 (Reuters) - Shenzhen Salubris Pharmaceuticals Co Ltd <002294.SZ>::SAYS IT PLANS SHARE BUYBACK SCHEME WORTH UP TO 200 MILLION YUAN ($30.86 million) WITHIN 12 MONTHS.

Shenzhen Salubris Pharma' Unit To Sell Entire 13.78% Stake In M.A. Med Alliance SA

June 14 (Reuters) - Shenzhen Salubris Pharmaceuticals Co Ltd <002294.SZ>::SAYS UNIT AGREES TO SELL ITS ENTIRE 13.78% STAKE IN M.A. MED ALLIANCE SA FOR $45 MILLION TO ROSY METRO LTD.

Shenzhen Salubris Pharmaceuticals Gets Regulator's Approval For Share Private Placement

Feb 22 (Reuters) - Shenzhen Salubris Pharmaceuticals Co Ltd <002294.SZ>::SAYS IT GETS SECURITIES REGULATOR'S APPROVAL FOR SHARE PRIVATE PLACEMENT.

Shenzhen Salubris Pharma Cuts Share Issue Size, Plans To Spin off Unit For Listing

Dec 11 (Reuters) - Shenzhen Salubris Pharmaceuticals Co Ltd <002294.SZ>::SAYS IT CUTS SHARE PRIVATE PLACEMENT SIZE TO 1.98 BILLION YUAN ($302.50 million) FROM 2.0 BILLION YUAN.SAYS IT PLANS TO SPIN OFF BIOMEDICAL ENGINEERING UNIT FOR LISTING IN DOMESTIC STOCK EXCHANGE.

Shenzhen Salubris Pharmaceuticals' H1 Net Profit Down 68.9% Y/Y

Aug 26 (Reuters) - Shenzhen Salubris Pharmaceuticals Co Ltd <002294.SZ>::SAYS H1 NET PROFIT DOWN 68.9% Y/Y.

Shenzhen Stock Exchange Filing Shows Block Trade Of Shenzhen Salubris Pharmaceuticals' Shares Involving 236.1 Mln Yuan

July 23 (Reuters) - Shenzhen Stock Exchange Filing Shows::BLOCK TRADE OF SHENZHEN SALUBRIS PHARMACEUTICALS CO LTD'S <<<002294.SZ>>> 6.9 MILLION SHARES INVOLVING 236.1 MILLION YUAN ($33.76 million) ON JULY 23.

Shenzhen Salubris Pharmaceuticals' Net Profit Falls In 2019, Q1

April 10 (Reuters) - Shenzhen Salubris Pharmaceuticals <002294.SZ>::SAYS 2019 NET PROFIT DOWN 51.0% Y/Y AT 715.2 MILLION YUAN.SAYS Q1 NET PROFIT DOWN 53.3% Y/Y AT 150.1 MILLION YUAN.

Shenzhen Salubris Pharmaceutical's Prelim 2019 Net Profit Down 51.4% Y/Y

Feb 28 (Reuters) - Shenzhen Salubris Pharmaceutical Co Ltd <002294.SZ>::SAYS PRELIM 2019 NET PROFIT DOWN 51.4% Y/Y AT 709.1 MILLION YUAN.

Shenzhen Salubris Pharma's 9-Month Net Profit Down 37.7% Y/Y

Oct 28 (Reuters) - Shenzhen Salubris Pharmaceuticals Co Ltd <002294.SZ>::SAYS 9-MONTH NET PROFIT DOWN 37.7% Y/Y.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up